Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adler-Shohet, F
Right arrow Articles by Lieberman, J M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adler-Shohet, F
Right arrow Articles by Lieberman, J M
Arch Dis Child Fetal Neonatal Ed 2001;84:F131-F133 ( March )

Short report

Amphotericin B lipid complex for neonatal invasive candidiasis F Adler-Shoheta, H Waskinb, J M Liebermana

a Miller Children's Hospital, Long Beach, California and University of California, Irvine, California, USA, b The Liposome Company, Princeton, New Jersey, USA

Correspondence to: Dr Lieberman, Pediatric Infectious Diseases, Miller Children's Hospital, 2801 Atlantic Ave, PO Box 1428, Long Beach, CA 90801-1428, USA jmlieberman{at}pol.net

Accepted 26 September 2000

This study describes the safety and efficacy of amphotericin B lipid complex (ABLC) in 11 neonates with systemic Candida infections. Nine of the 11 improved clinically, and eight of nine evaluable patients had a mycological cure with ABLC. Creatinine levels improved or did not significantly change in eight of the 11 patients.


Keywords: Candida; neonate; amphotericin B lipid complex

© 2001 by Archives of Disease in Childhood


This article has been cited by other articles:


Home page
 PediatricsHome page
C. C. Blyth, P. Palasanthiran, and T. A. O'Brien
Antifungal Therapy in Children With Invasive Fungal Infections: A Systematic Review
Pediatrics, April 1, 2007; 119(4): 772 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
L Clerihew, T L Lamagni, P Brocklehurst, and W McGuire
Invasive fungal infection in very low birthweight infants: national prospective surveillance study
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2006; 91(3): F188 - F192.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. Holler, S. A. Omar, M. D. Farid, and M. J. Patterson
Effects of Fluid and Electrolyte Management on Amphotericin B-Induced Nephrotoxicity Among Extremely Low Birth Weight Infants
Pediatrics, June 1, 2004; 113(6): e608 - e616.
[Abstract] [Full Text]

Home page
 J Antimicrob ChemotherHome page
N. Linder, G. Klinger, I. Shalit, I. Levy, S. Ashkenazi, G. Haski, O. Levit, and L. Sirota
Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations
J. Antimicrob. Chemother., October 1, 2003; 52(4): 663 - 667.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health